Burke & Herbert Bank & Trust CO Abbott Laboratories Transaction History

Burke & Herbert Bank & Trust CO

$410 Million
Q3 2024

A detailed history of Burke & Herbert Bank & Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Burke & Herbert Bank & Trust CO holds 15,407 shares of ABT stock, worth $1.81 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

15,407

Previous 15,875 2.95%

Holding current value

$1.81 Million

Previous $1.65 Million 6.49%

% of portfolio

0.43%

Previous 0.43%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$100.07 - $118.13 $46,832 - $55,284	-468 Reduced 2.95%	15,407 $1.76 Million
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $511,003 - $570,408	5,073 Added 46.96%	15,875 $1.65 Million
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $35,594 - $39,312	-325 Reduced 2.92%	10,802 $1.23 Million
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $360 - $441	-4 Reduced 0.04%	11,127 $1.22 Million
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $62,763 - $75,305	-657 Reduced 5.57%	11,131 $1.08 Million
Q2 2023 Jul 12, 2023	SELL	$100.78 - $112.29 $11,992 - $13,362	-119 Reduced 1.0%	11,788 $1.29 Million
Q1 2023 Apr 13, 2023	SELL	$96.86 - $114.01 $23,149 - $27,248	-239 Reduced 1.97%	11,907 $1.21 Million
Q2 2022 Jul 08, 2022	SELL	$102.07 - $123.37 $108,908 - $131,635	-1,067 Reduced 8.08%	12,146 $1.32 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $100,109 - $122,077	-878 Reduced 6.23%	13,213 $1.56 Million
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $13,065 - $14,454	-112 Reduced 0.79%	14,091 $1.66 Million
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $8,357 - $9,837	-79 Reduced 0.55%	14,203 $1.65 Million
Q1 2021 Apr 12, 2021	SELL	$108.84 - $128.23 $142,253 - $167,596	-1,307 Reduced 8.38%	14,282 $1.71 Million
Q4 2020 Jan 11, 2021	SELL	$105.0 - $114.42 $66,150 - $72,084	-630 Reduced 3.88%	15,589 $1.71 Million
Q3 2020 Oct 06, 2020	SELL	$91.64 - $111.29 $458 - $556	-5 Reduced 0.03%	16,219 $1.77 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $8,499 - $10,878	-111 Reduced 0.68%	16,224 $1.48 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $14,385 - $21,035	-229 Reduced 1.38%	16,335 $1.29 Million
Q4 2019 Jan 08, 2020	BUY	$78.51 - $87.4 $94,761 - $105,491	1,207 Added 7.86%	16,564 $1.44 Million
Q3 2019 Oct 08, 2019	SELL	$81.84 - $88.74 $5,892 - $6,389	-72 Reduced 0.47%	15,357 $1.29 Million
Q2 2019 Jul 16, 2019	SELL	$72.88 - $85.0 $26,965 - $31,450	-370 Reduced 2.34%	15,429 $1.3 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $11,588 - $14,010	-175 Reduced 1.1%	15,799 $1.26 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $13,439 - $15,225	-205 Reduced 1.27%	15,974 $1.16 Million
Q3 2018 Oct 10, 2018	SELL	$60.81 - $73.36 $3,344 - $4,034	-55 Reduced 0.34%	16,179 $1.19 Million
Q2 2018 Jul 06, 2018	BUY	$57.57 - $63.54 $15,256 - $16,838	265 Added 1.66%	16,234 $990,000
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $1,342 - $1,436	-25 Reduced 0.16%	15,969 $912,000
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $768,671 - $857,918	15,994	15,994 $853,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burke & Herbert Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Burke & Herbert Bank & Trust CO with notifications on news.

Account

Burke & Herbert Bank & Trust CO Abbott Laboratories Transaction History